{{Rsnum
|rsid=37972
|Gene=GLCCI1
|Chromosome=7
|position=7967878
|Orientation=plus
|GMAF=0.3742
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=AC009473.1,GLCCI1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 55.8 | 16.8
| HCB | 34.3 | 46.0 | 19.7
| JPT | 39.8 | 44.2 | 15.9
| YRI | 73.4 | 24.5 | 2.1
| ASW | 50.9 | 40.0 | 9.1
| CHB | 34.3 | 46.0 | 19.7
| CHD | 28.4 | 43.1 | 28.4
| GIH | 19.8 | 50.5 | 29.7
| LWK | 82.7 | 15.5 | 1.8
| MEX | 31.0 | 46.6 | 22.4
| MKK | 0.0 | 0.0 | 0.0
| TSI | 37.6 | 49.5 | 12.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21991891
|Title=Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma
|OA=1
}}

{{PMID Auto
|PMID=25091946
|Title=Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids
}}

{{PMID Auto
|PMID=25134782
|Title=Rs37972 and rs37973 single-nucleotide polymorphisms in the Glucocorticoid-inducible 1 gene are not associated with asthma risk in a Saudi Arabian population
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}